SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-22-009385
Filing Date
2022-07-07
Accepted
2022-07-07 16:33:58
Documents
15
Period of Report
2022-06-30
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K zivo_8k.htm   iXBRL 8-K 25624
2 SECOND AMENDED AND RESTATED zivo_ex31.htm EX-3.1 103012
  Complete submission text file 0001654954-22-009385.txt   278847

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zivo-20220630.xsd EX-101.SCH 5720
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zivo-20220630_lab.xml EX-101.LAB 15214
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zivo-20220630_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zivo-20220630_pre.xml EX-101.PRE 9640
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zivo-20220630_def.xml EX-101.DEF 2099
9 EXTRACTED XBRL INSTANCE DOCUMENT zivo_8k_htm.xml XML 3726
Mailing Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304
Business Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304 (248) 452 9866
Zivo Bioscience, Inc. (Filer) CIK: 0001101026 (see all company filings)

IRS No.: 870699977 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40449 | Film No.: 221072000
SIC: 2836 Biological Products, (No Diagnostic Substances)